Biogen (NASDAQ:BIIB – Get Free Report) issued its earnings results on Friday. The biotechnology company reported $1.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.27, FiscalAI reports. Biogen had a net margin of 15.98% and a return on equity of 14.13%. The firm had revenue of $2.28 billion [...]
Biogen (NASDAQ:BIIB) Posts Quarterly Earnings Results, Beats Estimates By $0.27 EPS
